EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO

Immunic, Inc (NASDAQ:IMUX) announced it strengthened its enactment squad connected Wednesday arsenic the institution prepares to beforehand its aggregate sclerosis pipeline done late-stage improvement and imaginable commercialization.

Immunic Appoints Erik Lundgren As CEO

Immunic named biopharmaceutical enforcement Erik Lundgren arsenic CEO effectual May 22, 2026, with his employment opening June 1.

Lundgren succeeds Daniel Vitt, Ph.D., who volition proceed overseeing technological strategy and portfolio advancement portion remaining connected Immunic's committee of directors.

Company Advances Late-Stage Multiple Sclerosis Programs

Immunic said Lundgren volition pb the institution arsenic it advances vidofludimus calcium done late-stage objective development, including the pivotal signifier 3 ENSURE programme successful relapsing aggregate sclerosis and a planned signifier 3 programme successful superior progressive aggregate sclerosis.

The institution is besides preparing for imaginable regulatory filings, support efforts, and commercialization activities.

Lundgren Brings Deep Genentech And MS Experience

Lundgren joins Immunic with astir 2 decades of acquisition spanning commercialized strategy, marketing, merchandise launches, portfolio leadership, and wide management, peculiarly successful aggregate sclerosis.

He astir precocious served arsenic elder vice president of the Commercial Portfolio Organization astatine Genentech, portion of Roche Group (OTC:RHHBY), aft antecedently starring Roche Czech Republic arsenic wide manager.

Earlier successful his career, helium supported the motorboat and commercialization of Ocrevus, a large attraction for RMS and PPMS, and besides worked connected oncology products including Kadcyla and Zelboraf.

Immunic's compensation committee granted Lundgren an equity enactment to acquisition 1 cardinal shares nether the company's 2026 inducement equity compensation plan.

IMUX Price Action: Immunic shares were up 1.32% astatine $13.14 during premarket trading connected Wednesday, according to Benzinga Pro data.

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click present to get apical commercialized ideas daily, positive unlimited entree to cutting-edge tools and strategies to summation an borderline successful the markets.

This nonfiction EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO primitively appeared connected Benzinga.com

© 2026 Benzinga.com. Benzinga does not supply concern advice. All rights reserved.